Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and

K Knauth1, C Bex, P Jemth

  • 1Department of Molecular Cell Biology, Max Planck Institute of Biochemistry, Martinsried, Germany.

Oncogene
|November 2, 2005
PubMed

Insights

Mutations in the von Hippel-Lindau (VHL) gene impact cancer risk. Type 2A VHL disease mutants retain more activity against hypoxia-inducible transcription factor 1 (HIF-1alpha), suggesting a mechanism for lower renal cell carcinoma risk.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The von Hippel-Lindau (VHL) protein is crucial for regulating cellular processes as part of the CBC(VHL) E3 ubiquitin ligase complex.
  • Mutations in the VHL gene are linked to diverse tumors, with distinct VHL disease types (2A and 2B) showing different risks for renal cell carcinoma.

Purpose of the Study:

  • To elucidate the molecular differences between VHL disease types 2A and 2B.
  • To investigate the impact of specific VHL mutations (Y98H, Y112H in type 2A; Y98N, Y112N in type 2B) on protein stability, substrate binding, and enzymatic activity.

Main Methods:

  • Biochemical analysis of VHL mutant proteins.
  • Assessment of CBC(VHL) complex assembly.
  • Measurement of VHL mutant protein stability at physiological temperatures.
  • Determination of binding affinities for hypoxia-inducible transcription factor 1 (HIF-1alpha).
  • In vitro ubiquitin ligase activity assays using HIF-1alpha as a substrate.

Main Results:

  • Type 2A VHL mutations (Y98H, Y112H) resulted in more stable mutant proteins compared to type 2B mutations (Y98N, Y112N).
  • Type 2A mutants exhibited enhanced binding affinity for HIF-1alpha.
  • Type 2A VHL mutants retained significant ubiquitin ligase activity towards HIF-1alpha in vitro, unlike type 2B mutants.

Conclusions:

  • The increased stability and higher binding affinity of type 2A VHL mutants for HIF-1alpha contribute to their residual ubiquitin ligase activity.
  • This retained enzymatic activity is proposed to be sufficient for suppressing renal cell carcinogenesis in type 2A VHL disease.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...